We invite you to join us on Thursday, December 11, 2014 at 7:00 pm EST for our next webinar of our Support and Education Webinar Series, Hope in Progress: Research Update. The Hydrocephalus Association (HA) has raised over $3 million to support hydrocephalus research. This webinar will showcase several exciting studies being conducted and explain how basic, translation, and clinical research can all impact the management and treatment of hydrocephalus. The presentation will also include an update on the newly launched Adult Hydrocephalus Clinical Research Network (AHCRN).
Register online today and please share this educational opportunity with friends, family and medical professionals!
WHEN
Thursday, December 11, 2014
7:00 pm – 8:30 pm EST
Event
Hope in Progress: Research Update
Suggested Audience
This webinar is ideal for anyone who wants to learn more about hydrocephalus research, the Adult Hydrocephalus Clinical Research Network, and HA funded research. We welcome patients, their families, health professionals and researchers to tune in to hear the latest on hydrocephalus research.
Meet the Presenters
Timothy Vogel, MD
Assistant Professor Neurosurgery and Developmental Biology, Cincinnati Children’s Hospital Medical Center
Dr. Vogel is a pediatric neurosurgeon and an Assistant Professor of pediatric neurosurgery and developmental biology at Cincinnati Children’s Hospital Medical Center. Dr. Vogel received a CSF Production, Flow, and Regulation, Therapeutics and Diagnostics award in 2013. His study, Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus, is focused on the cilia, or hair-like structures on the surface of neural progenitor cells in the brain. He is exploring whether or not abnormal signaling through the cilia contributes to the development of neonatal hydrocephalus. Identification of these key signaling pathways could lead to preventative therapies.
James P. McAllister, PhD
Professor of Neurosurgery, Washington University in St. Louis
Dr. McAllister is a professor of neurosurgery at Washington University in St. Louis. He received a B.A. in biology from Earlham College and a PhD in neurobiology from Purdue University. He was awarded an Established Investigator award in 2010 for his study, Novel neurobiological interventions for the treatment of hydrocephalus. Dr. McAllister’s study investigated the abnormal blockage of cerebrospinal fluid flow. The study used animal models and patient CSF to increase our understanding of the damage that occurs in the hydrocephalic brain. Using this information can help advance the development of novel transplantation therapies
Norman Relkin, MD, PhD
Associate Professor of Clinical Neurology, Weill Cornell Medical Center
Norman Relkin, MD, PhD is a neurologist, Director of the Weill Cornell Memory Disorders Program, and AHCRN principal investigator at Weill Cornell Medical Center. Dr. Relkin is an expert in neuroimaging and directing the development of the AHCRN Imaging Database. The image data base will collect and maintain MRI and other scans which can be used to follow structural changes in the brain within a patient, but will also be used in future clinical studies. These studies may assess the success of different treatment options, determine the best option for shunt placement, or be used to develop noninvasive diagnostic techniques for NPH. By centralizing and standardizing images in the database, the AHCRN will be able to conduct high quality research more quickly.
Sponsors
This Webinar Series is made possible through the generosity of our industry partners The Batterman Foundation, Medtronic, Aesculap and Sophysa who we thank for supporting this important program!




There are no comments published yet.